Abcam PLC ADS (ABCZY) Financials Nov 13, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Abcam PLC ADS (ABCZY) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Abcam PLC ADS


Fiscal year is July-June. All values GBP millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 71.11M 83.27M 97.84M 122.21M 127.95M
Cost of Goods Sold (COGS) incl. D&A 23.87M 27.45M 31.53M 39.34M 42.4M
COGS excluding D&A 22.34M 25.86M 28.81M 33.51M 35.69M
Depreciation & Amortization Expense 1.53M 1.59M 2.72M 5.83M 6.71M
Depreciation 1.35M 1.38M 1.47M 1.99M 1.88M
Amortization of Intangibles 180,000 210,000 1.24M 3.84M 4.83M
Gross Income 47.24M 55.82M 66.31M 82.87M 85.55M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 21.44M 24.06M 28.68M 39.62M 42.44M
Research & Development 3.7M 3.23M 3.69M 6.19M 8.31M
Other SG&A 17.74M 20.83M 25M 33.43M 34.14M
Other Operating Expense 0 0 0 0 0
Unusual Expense 147,000 38,000 3.4M 400,000 (201,000)
EBIT after Unusual Expense (147,000) (38,000) (3.4M) (400,000) 201,000
Non Operating Income/Expense 0 (8,000) (73,000) (83,000) 0
Non-Operating Interest Income 184,000 398,000 500,000 129,000 238,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 0 0 0
Gross Interest Expense 0 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income 25.83M 32.11M 34.66M 42.89M 43.55M
Income Tax 6.61M 8.31M 9.26M 10.24M 9.51M
Income Tax - Current Domestic 6.92M 8.97M 9.74M 10.08M 9.98M
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic (310,000) (666,000) (485,000) 152,000 (478,000)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 19.22M 23.81M 25.41M 32.66M 34.05M
Minority Interest Expense 0 0 0 0 0
Net Income 19.22M 23.81M 25.41M 32.66M 34.05M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 19.22M 23.81M 25.41M 32.66M 34.05M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 19.22M 23.81M 25.41M 32.66M 34.05M
EPS (Basic) 0.11 0.13 0.14 0.17 0.17
Basic Shares Outstanding 178.57M 179.87M 185.13M 197.74M 198.86M
EPS (Diluted) 0.11 0.13 0.13 0.16 0.17
Diluted Shares Outstanding 182.88M 183.41M 188.51M 199.92M 200.02M
EBITDA 27.33M 33.35M 40.35M 49.08M 49.83M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 235

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 41

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 68

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 22

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 0

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
icles